Biomimetic Innovations gets US FDA breakthrough device designation for OsStic Synthetic Injectable Structural Bio-Adhesive Bone Void Filler
Pharmabiz.com,
Biomimetic Innovations Ltd announced that OsStic has been granted ‘Breakthrough Device’ designation by the FDA.